| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000013112 |
| Receipt No. | R000015298 |
| Official scientific title of the study | Evaluation of clinical applications of fluorescent imaging to liver surgery using injection of indocyanine green on the previous day of the operation |
| Date of disclosure of the study information | 2014/04/01 |
| Last modified on | 2016/04/05 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Evaluation of clinical applications of fluorescent imaging to liver surgery using injection of indocyanine green on the previous day of the operation | |
| Title of the study (Brief title) | Injection of indocyanine green on the previous day for the detection of small liver cancers | |
| Region |
|
|
| Condition | ||
| Condition | Liver cancers | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The detection of small liver cancers using indocyanine green fluorescent imaging through the injection of indocyanine green on the previous day |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | The detection of small liver cancers |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | indocyanine green | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Written informed concent | |||
| Key exclusion criteria | Other conditions considered inappropriate by attending physician | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Masaki Kaibori |
| Organization | Kansai Medical University |
| Division name | Surgery |
| Address | 2-5-1 Shinmachi, Hirakata city, Osaka |
| TEL | 072-804-0101 |
| kaibori@hirakata.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Kosuke Matsui |
| Organization | Kansai Medical University |
| Division name | Surgery |
| Address | 2-5-1 Shinmachi, Hirakata city, Osaka |
| TEL | 072-804-0101 |
| Homepage URL | |
| matsuik@hirakata.kmu.ac.jp | |
| Sponsor | |
| Institute | Department of Surgery, Kanai Medical University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Surgery, Kanai Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000015298 |